A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after study

PLoS Medicine

Volumn 17, Issue 8 August, 2020, Pages

  Galatas, Beatriz ^a,b   Saúte, Francisco ^b   Martí Soler, Helena ^a   Guinovart, Caterina ^a   Nhamussua, Lidia ^b   Simone, Wilson ^b   Munguambe, Humberto ^b   Hamido, Camilo ^b   Montañà, Júlia ^a,b   Muguande, Olinda ^c   Maartens, Francois ^d   Luis, Fabião ^b   Paaijmans, Krijn ^a,b,e   Mayor, Alfredo ^a,b,f   Bassat, Quique ^a,b,f,g   Menéndez, Clara ^a,b,f   Macete, Eusebio ^b,h   Rabinovich, Regina ^a,i   Alonso, Pedro L ^a   Candrinho, Baltazar ^j   Aide, Pedro ^b,h   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b Manhiça Health Research Center   (Mozambique)

^c Fundação Para O Desenvolvimento da Comunidade   (Mozambique)

^d Good Bye Malaria   (South Africa)

^e ARIZONA STATE UNIVERSITY   (United States)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^h INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j MINISTRY OF HEALTH   (Mozambique)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; DIHYDROARTEMISININ; PIPERAQUINE; PYRETHROID; PYRIMETHAMINE PLUS SULFADOXINE; SULFADOXINE; ANTIMALARIAL AGENT;

ABDOMINAL PAIN; ARTICLE; ASCARIS LUMBRICOIDES; ASTHENIA; BODY MASS; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DISEASE ELIMINATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DIZZINESS; FEVER; HEADACHE; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HUMAN; HYPOGLYCEMIA; LEPROSY; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MASS DRUG ADMINISTRATION; MOZAMBIQUE; PARASITE TRANSMISSION; PARTICULATE MATTER; PREVALENCE; QUESTIONNAIRE; SEA SURFACE TEMPERATURE; SEASONAL VARIATION; TUBERCULOSIS; VISCERAL LEISHMANIASIS; VOMITING; ADOLESCENT; ADULT; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; INFECTION CONTROL; MALE; MIDDLE AGED; MOSQUITO CONTROL; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFECTION CONTROL; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; MOSQUITO CONTROL; MOZAMBIQUE; YOUNG ADULT;

EID: 85089549852     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/JOURNAL.PMED.1003227     Document Type: Article

References (44)

1. Ministério da Saúde (MISAU), Instituto Nacional de Estatística (INE), ICF Internacional. Inquérito de Indicadores de Imunização, Malária e HIV/SIDA em Moçambique 2015. Survey of Indicators on Immunization, Malaria and HIV/AIDS in Mozambique. Rockville, Maryland, EUA: INS, INE e ICF International; 2015. Available from: https://dhsprogram.com/pubs/pdf/AIS12/AIS12.pdf
2. Griffin JT, Bhatt S, Sinka ME, Gething PW, Lynch M, Patouillard E, et al. Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study. Lancet Infect Dis. 2016; 16:465–72. https://doi.org/10.1016/S1473-3099(15) 00423-5 PMID: 26809816
3. Alonso P, Noor AM. The global fight against malaria is at crossroads. The Lancet. 2017; 390:2532–4.
4. Arroz JAH. Increase in cases of malaria in Mozambique, 2014: epidemic or new endemic pattern? Rev Saúde Pública. 2016; 50.
5. Moonasar D, Maharaj R, Kunene S, Candrinho B, Saute F, Ntshalintshali N, et al. Towards malaria elimination in the MOSASWA (Mozambique, South Africa and Swaziland) region. Malar J. 2016; 15.
6. Sharp BL, Kleinschmidt I, Streat E, Maharaj R, Barnes KI, Durrheim DN, et al. Seven years of regional malaria control collaboration—Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg. 2007; 76:42–47. PMID: 17255227
7. World Health Organization, Global Malaria Programme. Global technical strategy for malaria, 2016–2030. 2015 [cited 2020 Jul 30]. Available from: https://www.who.int/malaria/areas/global_technical_strategy/en/
8. World Health Organization (WHO). Eliminating Malaria. World Health Organization; 2016 [cited 2020 Jul 30]. Available from: https://www.who.int/malaria/publications/atoz/eliminating-malaria/en/
9. Aide P, Candrinho B, Galatas B, Munguambe K, Guinovart C, Luis F, et al. Setting the scene and generating evidence for malaria elimination in Southern Mozambique. Malar J. 2019; 18:190. https://doi.org/10.1186/s12936-019-2832-9 PMID: 31170984
10. Kloke RG, Nhamahanga E, Hunt RH, Coetzee M. Vectorial status and insecticide resistance of Anopheles funestus from a sugar estate in southern Mozambique. Parasit Vectors. 2011; 4:16. https://doi.org/10.1186/1756-3305-4-16 PMID: 21306631
11. Aranda C, Aponte JJ, Saute F, Casimiro S, Pinto J, Sousa C, et al. Entomological characteristics of malaria transmission in Manhiça, a rural area in southern Mozambique. J Med Entomol. 2005; 42:180–6. https://doi.org/10.1093/jmedent/42.2.180 PMID: 15799528
12. Cuamba N, Morgan JC, Irving H, Steven A, Wondji CS. High Level of Pyrethroid Resistance in an Anopheles funestus Population of the Chokwe District in Mozambique. PLoS ONE. 2010; 5:e11010. https://doi.org/10.1371/journal.pone.0011010 PMID: 20544036
13. Glunt KD, Abílio AP, Bassat Q, Bulo H, Gilbert AE, Huijben S, et al. Long-lasting insecticidal nets no longer effectively kill the highly resistant Anopheles funestus of southern Mozambique. Malar J. 2015; 14:298. https://doi.org/10.1186/s12936-015-0807-z PMID: 26242977
14. Salvador C, Rafael B, Matsinhe F, Candrinho B, Muthemba R, De Carvalho E, et al. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria at sentinel sites in Mozambique, 2015. Acta Trop. 2017; 171:146–50. https://doi.org/10.1016/j.actatropica.2017.03.032 PMID: 28373036
15. Galatas B, Nhacolo A, Martí-Soler H, Munguambe H, Jamise E, Guinovart C, et al. Demographic and health community-based surveys to inform a malaria elimination project in Magude district, southern Mozambique. BMJ Open. 2020; 10:e033985. https://doi.org/10.1136/bmjopen-2019-033985 PMID: 32371510
16. Arroz JAH, Candrinho B, Pedro S, Mathe G, da Silva M, Tsabete S, et al. Planning and implementation of a countrywide campaign to deliver over 16 million long-lasting insecticidal nets in Mozambique. Malar J. 2018; 17.
17. Swysen C, Bruls M, Oyakhirome S, Drakeley C, Okech B, Carter T, et al. Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine. Malar J. 2011; 10:223. https://doi.org/10.1186/1475-2875-10-223 PMID: 21816032
18. Brady OJ, Slater HC, Pemberton-Ross P, Wenger E, Maude RJ, Ghani AC, et al. Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study. Lancet Glob Health. 2017; 5:E680–7. https://doi.org/10.1016/S2214-109X(17)30220-6 PMID: 28566213
19. Naimi B. rts: Raster Time Series Analysis. R package version 1.0–45. 2018 [cited 2020 Jul 30]. Available from: https://cran.r-project.org/web/packages/rts/rts.pdf
20. Funk C, Peterson P, Landsfeld M, Pedreros D, Verdin J, Shukla S, et al. The climate hazards infrared precipitation with stations—a new environmental record for monitoring extremes. Sci Data. 2015; 2:150066. https://doi.org/10.1038/sdata.2015.66 PMID: 26646728
21. Linden A. Conducting interrupted time-series analysis for single- and multiple-group comparisons. Stata J. 2015; 15:480–500.
22. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Infectious Diseases Group, editor. Cochrane Database Syst Rev. 2013; 12: CD009946.
23. von Seidlein L, Greenwood BM. Mass administrations of antimalarial drugs. Trends Parasitol. 2003; 19:452–60. https://doi.org/10.1016/j.pt.2003.08.003 PMID: 14519583
24. Cui J, Qian G. Selection of Working Correlation Structure and Best Model in GEE Analyses of Longitudinal Data. Commun Stat—Simul Comput. 2007; 36:987–96.
25. R Core Team. R: A language and environment for statistical computing. Vienna, Austria; 2013 [cited 2020 Jul 30]. Available from: http://softlibre.unizar.es/manuales/aplicaciones/r/fullrefman.pdf
26. Chan XHS, Win YN, Mawer LJ, Tan JY, Brugada J, White NJ. Risk of sudden unexplained death after use of dihydroartemisinin–piperaquine for malaria: a systematic review and Bayesian meta-analysis. Lancet Infect Dis. 2018; 18:913–23. https://doi.org/10.1016/S1473-3099(18)30297-4 PMID: 29887371
27. Smith DL, Guerra CA, Snow RW, Hay SI. Standardizing estimates of the Plasmodium falciparum parasite rate. Malar J. 2007; 6:131. https://doi.org/10.1186/1475-2875-6-131 PMID: 17894879
28. Eisele TP, Bennett A, Silumbe K, Finn TP, Chalwe V, Kamuliwo M, et al. Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial. J Infect Dis. 2016; 214:1831–9. https://doi.org/10.1093/infdis/jiw416 PMID: 27923947
29. Deng C, Huang B, Wang Q, Wu W, Zheng S, Zhang H, et al. Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa. Clin Infect Dis. 2018; 67:1670–6. https://doi.org/10.1093/cid/ciy364 PMID: 29846536
30. Morris U, Msellem MI, Mkali H, Islam A, Aydin-Schmidt B, Jovel I, et al. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting—high coverage and safety, but no significant impact on transmission. BMC Med. 2018; 16:215. https://doi.org/10.1186/s12916-018-1202-8 PMID: 30526588
31. Gerardin J, Bever CA, Bridenbecker D, Hamainza B, Silumbe K, Miller JM, et al. Effectiveness of reactive case detection for malaria elimination in three archetypical transmission settings: a modelling study. Malar J. 2017; 16:248. https://doi.org/10.1186/s12936-017-1903-z PMID: 28606143
32. Selvaraj P, Wenger EA, Gerardin J. Seasonality and heterogeneity of malaria transmission determine success of interventions in high-endemic settings: a modeling study. BMC Infect Dis. 2018; 18:413. https://doi.org/10.1186/s12879-018-3319-y PMID: 30134861
33. Stuckey EM, Miller JM, Littrell M, Chitnis N, Steketee R. Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia’s southern province: a simulation study. Malar J. 2016; 15:148. https://doi.org/10.1186/s12936-016-1202-0 PMID: 26957364
34. Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007; 77:181–192. PMID: 18165491
35. Gerardin J, Bertozzi-Villa A, Eckhoff PA, Wenger EA. Impact of mass drug administration campaigns depends on interaction with seasonal human movement. Int Health. 2018; 10:252–7. https://doi.org/10.1093/inthealth/ihy025 PMID: 29635471
36. Smith JL, Auala J, Haindongo E, Uusiku P, Gosling R, Kleinschmidt I, et al. Malaria risk in young male travellers but local transmission persists: a case–control study in low transmission Namibia. Malar J. 2017; 16:70. https://doi.org/10.1186/s12936-017-1719-x PMID: 28187770
37. Slater HC, Ross A, Felger I, Hofmann NE, Robinson L, Cook J, et al. The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density. Nat Commun. 2019; 10:140. https://doi.org/10.1038/s41467-018-08059-z PMID: 30635559
38. Galatas B, Martí-Soler H, Nhamussua L, Cisteró P, Aide P, Saute F, et al. Dynamics of Afebrile Plasmodium falciparum Infections in Mozambican Men. Clin Infect Dis. 2018; 67:1045–52. https://doi.org/10.1093/cid/ciy219 PMID: 29546346
39. Killeen GF. Characterizing, controlling and eliminating residual malaria transmission. Malar J. 2014; 13:330. https://doi.org/10.1186/1475-2875-13-330 PMID: 25149656
40. Mwesigwa J, Achan J, Affara M, Wathuo M, Worwui A, Mohammed NI, et al. Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study. Clin Infect Dis. 2018; 69:278–86.
41. Molineaux L, Gramiccia G. The Garki Project. World Health Organization; 1980.
42. Cheah PY, White NJ. Antimalarial mass drug administration: ethical considerations. Int Health. 2016; 8:235–8. https://doi.org/10.1093/inthealth/ihw027 PMID: 27481834
43. World Health Organization. WHO Evidence Review Group on the cardiotoxicity of antimalarials. World Health Organization, Geneva; 2017 [cited 2020 Jul 30]. Available from: https://www.who.int/malaria/mpac/mpac-mar2017-erg-cardiotoxicity-report-session2.pdf?ua=1
44. Cirera L, Galatas B, Alonso S, Paaijmans K, Mamuquele M, Martí-Soler H, et al. Moving towards malaria elimination in southern Mozambique: Cost and cost-effectiveness of mass drug administration combined with intensified malaria control. PLoS ONE. Public Library of Science; 2020; 15:e0235631. https://doi.org/10.1371/journal.pone.0235631 PMID: 32628741